Academy of Immunohistochemistry

Program

09.00 – 10.00
Registration and coffee
10.00 – 10.15
Janusz Ryś – Opening remarks
10.15 – 11.00
M. Miettinen – The most important innovations in immunohistochemistry that have changed cancer diagnostics in the last decade
11.00 – 11.45
J. Hornick – Next-generation immunohistochemistry for soft tissue tumors and beyond
11.45 – 12.30
O. Carpen – Diagnostic Molecular Pathology in the next decade
12.30 – 13.30
Lunch
13.30 – 14.15
A. Bellizzi – Differentiating the Undifferentiated: Algorithmic IHC Approach
14.15 – 15.00
A. Malpica – Useful IHC algorithms for gynecological pathology
15.00 – 15.45
P. Dundr – Diagnostic molecular pathology of uterine mesenchymal tumors
15.45 – 16.15
Coffee Break
16.15 – 17.00
A. Malpica – Germ Cell Tumors of the Ovary. A Practical Review
17.00 – 17.45
J. Stanek – Immunohistochemistry in placental pathology
17.45 – 18.30
A. Kowalewski and Ł. Szylberg – Immunohistochemical and molecular diagnostics tailoring personalized ovarian cancer therapy

08.30 – 09.15
A. Porwit – EBV related lymphomas and other EBV related lymphoid proliferations
09.15 – 10.00
M. Prochorec-Sobieszek – T-cell lymphomas – immunohistochemical and molecular approach
10.00 – 10.30
M. Tyburczy – New technologies in the genomic evaluation of lymphomas
10.30 – 11.00
Coffee Break
11.00 – 11.45
T. Mentzel – Immunohistochemistry in differential diagnosis of spindle cell tumors in skin and subcutis
11.45 – 12.30
T. Mentzel – Pitfalls in the diagnosis of melanocytic neoplasms – is immunohistochemistry of help?
12.30 – 13.30
Lunch
13.30 – 14.15
A. Mróz – Everyday practice and future perspectives in colorectal pathology
14.15 – 15.00
A. Bellizzi – Problem-Based Approach to Pancreatic Pathology
15.00 – 15.30
Coffee Break
15.30 – 16.15
M. Eckstein – Differential ADC target expression in different morphological and molecular subtypes of urothelial carcinoma
16.15 – 17.00
M. Eckstein – Spatial transcriptomic profiling of metastatic renal cell carcinoma
17.00 – 18.00
CASE PRESENTATIONS (4 unusual cases)

08.30 – 09.15
K. Bøgh Anderson and S. Nielsen – Quality Review on Most Commonly Used IHC assays-Expectations, Disappointments and Challenges During Last Decade (NordiQC)
09.15 – 10.00
A. Marszałek – Quality of pathologist training in the immunohistochemistry and molecular biology in the EU
10.00 – 10.30
Coffee Break
10.30 – 11.15
G. Sauter – Large-scale Tissue Microarray resources for the identification and evaluation of critical IHC markers
11.15 – 12.00
J. Lasota – Histological, immunohistochemical, and molecular characteristics of dedifferentiated and undifferentiated melanomas, and their distinction from other malignant tumors by the DNA methylation classifier
12.00 – 13.00
Lunch
13.00 – 13.45
J. Klijanienko – Auxillary tests in diagnostic cytology
13.45 – 14.30
R. Jach and M. Trzeszcz – p16/Ki67 DS ICC in cervical cancer prevention: Bridging immunoprofile and clinical decision making
14.30 – 15.00
Coffee Break
15.00 – 15.30
K. Korski – Generation of virtual stains-can AI imitate chemistry?
15.30 – 16.00
Ż. Świderska-Chadaj – The role of computational pathology in predicting expression of selected immunohistochemical markers
16.00 – 16.30
Multimodal algorithms in digital pathology (be announced)
16.30
J. Rys – Closing remarks

22nd June 2026, 20.00 – 22.00
Course Dinner
NOTE
The accompanying event is not financed by funds from innovative companies affiliated with INFARMA. Participation in the dinner is free of charge. All course participants are cordially invited to attend the dinner. The dinner is made possible by the generous support of our sponsors.